Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study

被引：0
|
作者：
Sverdloff, Carlos [1 ,3 ]
Page, Clive [4 ]
De Nucci, Gilberto [1 ,2 ]
Singh, Dave [5 ]
机构：
[1] Univ Estadual Campinas, Campinas, Brazil
[2] Univ Sao Paulo, Sao Paulo, Brazil
[3] ATCGen, Campinas, Brazil
[4] Kings Coll London, London, England
[5] Univ Manchester, Manchester, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OC160
引用
收藏
页码：226 / 228
页数：3
相关论文
共 50 条
  • [1] Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study
    DeNucci, Gilberto
    Wilkinson, Tom
    Sverdloff, Carlos
    Babadopulos, Tainah
    Woodcock, Ashley
    Shute, Jan
    Guazelli, Pedro Renato
    Gerbase, Luis Frederico
    Mourao, Paulo A. S.
    Singh, Dave
    van Haren, Frank M. P.
    Page, Clive
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 80
  • [2] Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patients
    van Haren, Frank M. P.
    van Loon, Lex M.
    Steins, Anne
    Smoot, Thomas L.
    Sas, Caitlin
    Staas, Sabrina
    Vilaseca, Alicia B.
    Barbera, Ruben A.
    Vidmar, Gustavo
    Beccari, Hugo
    Popilevsky, Frida
    Daribayeva, Eleonora
    Venkatesan, Bhuvaneshwari
    Mozes, Susan
    Postel, Rachel
    Popilevski, Natalie
    Webb, Andrew
    Nunes, Quentin
    Laffey, John G.
    Artigas, Antonio
    Smith, Roger
    Dixon, Barry
    Richardson, Alice
    Yoon, Hwan-Jin
    Page, Clive
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2802 - 2813
  • [3] INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies
    van Haren, Frank M. P.
    Richardson, Alice
    Yoon, Hwan-Jin
    Artigas, Antonio
    Laffey, John G.
    Dixon, Barry
    Smith, Roger
    Vilaseca, Alicia B.
    Barbera, Ruben A.
    Ismail, Tarek I.
    Mahrous, Rabab S.
    Badr, Mohamed
    De Nucci, Gilberto
    Sverdloff, Carlos
    van Loon, Lex M.
    Camprubi-Rimblas, Marta
    Cosgrave, David W.
    Smoot, Thomas L.
    Staas, Sabrina
    Sann, Khine
    Sas, Caitlin
    Belani, Anusha
    Hillman, Christopher
    Shute, Janis
    Carroll, Mary
    Wilkinson, Tom
    Carroll, Miles
    Singh, Dave
    Page, Clive
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (08) : 3075 - 3091
  • [4] A randomised, open-label trial of nebulised unfractionated heparin in patients mechanically ventilated for COVID-19
    Smith, Roger J.
    Ghosh, Angajendra N.
    Said, Simone
    van Haren, Frank M. P.
    Laffey, John G.
    Doig, Gordon S.
    Santamaria, John D.
    Dixon, Barry
    ANAESTHESIA AND INTENSIVE CARE, 2025,
  • [5] Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
    Frank M. P. van Haren
    Clive Page
    John G. Laffey
    Antonio Artigas
    Marta Camprubi-Rimblas
    Quentin Nunes
    Roger Smith
    Janis Shute
    Mary Carroll
    Julia Tree
    Miles Carroll
    Dave Singh
    Tom Wilkinson
    Barry Dixon
    Critical Care, 24
  • [6] Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
    van Haren, Frank M. P.
    Page, Clive
    Laffey, John G.
    Artigas, Antonio
    Camprubi-Rimblas, Marta
    Nunes, Quentin
    Smith, Roger
    Shute, Janis
    Carroll, Mary
    Tree, Julia
    Carroll, Miles
    Singh, Dave
    Wilkinson, Tom
    Dixon, Barry
    CRITICAL CARE, 2020, 24 (01)
  • [7] Role of Nebulised Heparin as an Adjunct in Critically-ill COVID-19 Patients: A Randomised Controlled Trial
    Nagalingareddy, Arun
    Srividya, Peram
    Shivakumara, K. C.
    Raghu, S. P.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (12) : UC20 - UC23
  • [8] Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
    Agusti, Alvar
    De Stefano, Gaston
    Levi, Alberto
    Munoz, Xavier
    Romero-Mesones, Christian
    Sibila, Oriol
    Lopez-Giraldo, Alejandra
    Moral, Vicente Plaza
    Curto, Elena
    Echazarreta, Andres L.
    Marquez, Silvana E.
    Pascual-Guardia, Sergi
    Santos, Salud
    Marin, Alicia
    Valdes, Luis
    Saldarini, Fernando
    Salgado, Clara
    Casanovas, Georgina
    Varea, Sara
    Rios, Jose
    Faner, Rosa
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (03)
  • [9] Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trial
    Kralj-Hans, Ines
    Li, Kuo
    Wesek, Adrian
    Lamorgese, Alexia
    Omar, Fatima
    Ranasinghe, Kapila
    McGee, Megan
    Brack, Kieran
    Li, Shiliang
    Aggarwal, Ritesh
    Bulle, Ajay
    Kodre, Aparna
    Sharma, Shashank
    Fluck, David
    John, Isaac
    Sharma, Pankaj
    Belsey, Jonathan D.
    Li, Ling
    Seshasai, Sreenivasa Rao Kondapally
    Li, Hong Lin
    Marczin, Nandor
    Chen, Zhong
    BMJ OPEN, 2023, 13 (04):
  • [10] Inhaled ciclesonide in adults hospitalised with COVID-19: a randomised controlled open-label trial (HALT COVID-19)
    Brodin, Daniel
    Tornhammar, Per
    Ueda, Peter
    Krifors, Anders
    Westerlund, Eli
    Athlin, Simon
    Wojt, Sandra
    Elvstam, Olof
    Neumann, Anca
    Elshani, Arsim
    Giesecke, Julia
    Edvardsson-Kallkvist, Jens
    Bunpuckdee, Sayam
    Unge, Christian
    Larsson, Martin
    Johansson, Bjoern
    Ljungberg, Johan
    Lindell, Jonas
    Hansson, Johan
    Blennow, Ola
    Andersson, Daniel Peter
    BMJ OPEN, 2023, 13 (03):
12345